Skip to content

Therapeutic Agency as Process Factor in Inpatient Psychotherapy Treatment - An Investigation of the Measurement of Agency from Multiple Perspectives in Individual and Group Psychotherapy Settings

Therapeutic Agency as Process Factor in Inpatient Psychotherapy Treatment - An Investigation of the Measurement of Agency from Multiple Perspectives in Individual and Group Psychotherapy Settings - AGEMA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030339
Enrollment
150
Registered
2023-02-09
Start date
2023-02-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F99

Interventions

Group 1: Cross-sectional observational study with four measurement occasions scheduled over one year. Every three months, Patients at this time point enrolled in a psychotherapeutic inpatient or day-c
Lutz et al., 2006) and therapeutic agency in individual (German version of Therapeutic Agency Inventory, TAI
Huber at al., 2019) as well as group-based psychotherapy (newly developed version of TAI for group psychotherapy). A chosen individual psychotherapy session will be audio recorded
therapists and objective observers will be asked to rate the patients therapeutic agency in that session using a newly developed version of the TAI for therapist-rated and observer-rated patient agenc
Löwe et al., 2004), Generalized Anxiety Disorder questionnaire (GAD-7
Spitzer et al., 2006), Operationalized Psychodynamic Diagnosis-Structure Questionnaire (OPD-SF
Ehrenthal et al., 2012), Experiences in Close Relationships-Revised Questionnaire (ECR-RD8
Ehrenthal et al., 2021), and Inventory of Interpersonal Problems (IIP
Horowitz et al., 1988). In the week in which the assessment of agency in individual and group-based psychotherapy will take place, experiences in inpatient psychotherapy (IDES
Dinger et al., 2015) as well as symptom severity (SCL-K11) will be measured using questionnaires.

Sponsors

Klinik für Psychosomatische Medizin und Psychotherapie des LVR-Klinikums Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - ability to give consent - patient has given written consent - legal age (18 years of age) - at time point of measurement enrolled in inpatient or day-clinic psychotherapy program

Exclusion criteria

Exclusion criteria: - neither audio recording of individual psychotherapy session nor self-reported agency nor therapist-reported agency available

Design outcomes

Primary

MeasureTime frame
Data collection will be concluded as soon as all of the four measurement occasions scheduled over one year will be completed. The primary outcome consists in patients' therapeutic agency measured at different occasions (individual and group psychotherapy) and assessed from different perspectives (patients' self-report, therapists' report, observers' report). The objective is to develop and evaluate three new version of the TAI. At every measurement occasion, the following data will be assessed: - patients: gender, age, diagnoses, SCL-K11 (several assessments), TAI for individual psychotherapy session, newly developed version of TAI for group psychotherapy session, PHQ-9, GAD-7, OPD-SF, ECR-RD8, IIP, and IDES - therapists: newly developed version of TAI for therapist-rated patient agency - observers: newly developed version of TAI for observer-rated patient agency

Secondary

MeasureTime frame
The secondary outcome consists in the comparison of patient agency in individual vs. group psychotherapy.

Countries

Germany

Contacts

Public ContactUlrike Dinger-Ehrenthal

Klinik für Psychosomatische Medizin und Psychotherapie des LVR-Klinikums Düsseldorf, Kliniken der Heinrich-Heine-Universität Düsseldorf, Medizinische Fakultät, Heinrich-Heine-Universität Düsseldorf

ulrike.dinger-ehrenthal@lvr.de0211 922-4700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026